These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 10674451)
1. Tamoxifen for the prevention of breast cancer in the high-risk woman. Morrow M; Jordan VC Ann Surg Oncol; 2000; 7(1):67-71. PubMed ID: 10674451 [No Abstract] [Full Text] [Related]
2. Breast cancer chemoprevention--an update. Mokbel K; Singh-Ranger G Curr Med Res Opin; 2002; 18(6):329-31. PubMed ID: 12442878 [TBL] [Abstract][Full Text] [Related]
3. The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials. Martino S; Costantino J; McNabb M; Mershon J; Bryant K; Powles T; Secrest RJ Oncologist; 2004; 9(2):116-25. PubMed ID: 15047916 [TBL] [Abstract][Full Text] [Related]
5. Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results. Crowell EB; Jubelirer SJ W V Med J; 2000; 96(6):598-601. PubMed ID: 11194088 [TBL] [Abstract][Full Text] [Related]
6. Independent assessment supports a role for tamoxifen in breast cancer risk reduction. Oncology (Williston Park); 1999 Sep; 13(9):1211. PubMed ID: 10509317 [No Abstract] [Full Text] [Related]
7. Breast-cancer prevention: is the risk-benefit ratio in favour of tamoxifen? Bergh J Lancet; 2003 Jul; 362(9379):183-4. PubMed ID: 12885476 [No Abstract] [Full Text] [Related]
8. Targeted antiestrogens for the prevention of breast cancer. Bentrem DJ; Jordan VC Oncol Res; 1999; 11(9):401-7. PubMed ID: 10821534 [TBL] [Abstract][Full Text] [Related]
9. The breast cancer prevention trial: should women at risk take tamoxifen? McKeon VA J Obstet Gynecol Neonatal Nurs; 1999; 28(6 Suppl 1):34-8. PubMed ID: 10608495 [TBL] [Abstract][Full Text] [Related]
11. Keeping breast cancer at bay. Women at risk are asked to weigh the pros and cons of a prevention pill. Brink S US News World Rep; 1999 May; 126(21):76. PubMed ID: 10387894 [No Abstract] [Full Text] [Related]
12. Tamoxifen for prevention of breast cancer. Cersosimo RJ Ann Pharmacother; 2003 Feb; 37(2):268-73. PubMed ID: 12549959 [TBL] [Abstract][Full Text] [Related]
13. Tamoxifen for the prevention of breast cancer. Important questions remain unanswered, and existing trials should continue. Bruzzi P BMJ; 1998 Apr; 316(7139):1181-2. PubMed ID: 9552991 [No Abstract] [Full Text] [Related]
14. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. Powles TJ; Ashley S; Tidy A; Smith IE; Dowsett M J Natl Cancer Inst; 2007 Feb; 99(4):283-90. PubMed ID: 17312305 [TBL] [Abstract][Full Text] [Related]
15. Experts debate drugs for healthy women with breast cancer risk. Stephenson J JAMA; 1999 Jul; 282(2):117-8. PubMed ID: 10411178 [No Abstract] [Full Text] [Related]
17. Re: tamoxifen prevention of breast cancer: an instance of the fingerpost. Rockhill B; Colditz G; Kaye J J Natl Cancer Inst; 2000 Apr; 92(8):657-9. PubMed ID: 10772687 [No Abstract] [Full Text] [Related]
18. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women. Bevers TB J Natl Compr Canc Netw; 2007 Sep; 5(8):719-24. PubMed ID: 17927929 [TBL] [Abstract][Full Text] [Related]